tiprankstipranks
Trending News
More News >
Cellebrite DI (CLBT)
NASDAQ:CLBT
US Market
Advertisement

Cellebrite DI (CLBT) Earnings Dates, Call Summary & Reports

Compare
492 Followers

Earnings Data

Report Date
Feb 18, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.1
Last Year’s EPS
0.08
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Cellebrite DI Ltd. demonstrated strong growth in ARR and subscription revenue, with significant advancements in cloud and SaaS offerings. The company successfully expanded its defense and intelligence sector presence and saw recovery in the US Federal segment. However, challenges remain in the federal segment and delays in the Keryllium acquisition process. Overall, the company is well-positioned for continued growth, with strategic initiatives in place for 2026.
Company Guidance
During the Cellebrite DI Ltd. Third Quarter 2025 Financial Results Conference Call, the company reported significant growth metrics, including a 19% increase in Annual Recurring Revenue (ARR) to $440 million and a 21% rise in subscription revenue, driven by strong performance in the U.S. state and local segment and Latin America. Adjusted EBITDA grew by 20% year-over-year with a margin expansion of 60 basis points, while the company's free cash flow margin reached 31% over the trailing twelve months. The call highlighted the successful conversion of 47% of the installed digital forensics license base to the company's Insights offering, with a target of 50% conversion by year-end. Additionally, the company's SaaS and cloud-based solutions' ARR grew three times faster than the total ARR, with the Guardian platform achieving triple-digit ARR growth for the fifth consecutive quarter. The company remains optimistic about its strategic focus on the global defense and intelligence sector, expecting continued growth and leadership into 2026, and anticipates a resurgence in the U.S. federal sector as budgets normalize.
Strong ARR and Subscription Growth
Annual Recurring Revenue (ARR) grew by 19% to $440 million, while subscription revenue increased by 21%, led by strong performance in the US state and local segment and Latin America.
Adjusted EBITDA and Margin Expansion
Adjusted EBITDA exceeded expectations, growing 20% year-on-year with margin expansion of 60 basis points.
Cloud and SaaS Growth
ARR for SaaS and cloud-based solutions grew three times faster than total ARR, with Guardian's ARR growing triple digits for the fifth consecutive quarter.
Strategic Focus on Defense and Intelligence
Expanded business in global defense and intelligence sectors, with significant growth in Europe, supporting high-priority use cases across anti-terrorism and military readiness.
Federal Segment Recovery
The US Federal segment returned to growth in Q3, with strategic client expansions and anticipation of a strong rebound in 2026.

Cellebrite DI (CLBT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CLBT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 18, 2026
2025 (Q4)
0.10 / -
0.08
Nov 12, 2025
2025 (Q3)
0.09 / 0.08
-0.99108.08% (+1.07)
Aug 14, 2025
2025 (Q2)
0.08 / 0.08
-0.12166.67% (+0.20)
May 14, 2025
2025 (Q1)
0.05 / 0.07
-0.36119.44% (+0.43)
Feb 13, 2025
2024 (Q4)
0.07 / 0.08
-0.08200.00% (+0.16)
Nov 06, 2024
2024 (Q3)
0.07 / -0.99
0.03-3400.00% (-1.02)
Aug 15, 2024
2024 (Q2)
0.04 / -0.12
-0.1729.41% (+0.05)
May 23, 2024
2024 (Q1)
0.02 / -0.36
-0.21-71.43% (-0.15)
Feb 15, 2024
2023 (Q4)
0.03 / -0.08
0.04-300.00% (-0.12)
Nov 14, 2023
2023 (Q3)
0.03 / 0.03
0.13-76.92% (-0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CLBT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
$15.97$19.28+20.73%
Aug 14, 2025
$13.99$15.29+9.29%
May 14, 2025
$20.12$17.81-11.48%
Feb 13, 2025
$24.92$21.70-12.92%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cellebrite DI (CLBT) report earnings?
Cellebrite DI (CLBT) is schdueled to report earning on Feb 18, 2026, Before Open (Confirmed).
    What is Cellebrite DI (CLBT) earnings time?
    Cellebrite DI (CLBT) earnings time is at Feb 18, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CLBT EPS forecast?
          CLBT EPS forecast for the fiscal quarter 2025 (Q4) is 0.1.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis